Tp53-associated pediatric malignancies

41Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Although the majority of pediatric malignancies express wild-type p53, it is well established that germline TP53 mutations or functional inactivation of this pathway by other means contribute to childhood cancer. Epidemiology studies have revealed the existence of diverse inherited mutant TP53 alleles that display different levels of tumor suppressor activity, which correlate with cancer risk in terms of penetrance, age of onset, and tumor types. In this monograph, the authors describe those childhood cancers associated with functional inactivation of TP53 focusing on adrenocortical carcinoma as a model for tissues that are highly sensitive to loss of p53 activity. © The Author(s) 2011.

Cite

CITATION STYLE

APA

Pinto, E. M., Ribeiro, R. C., Figueiredo, B. C., & Zambetti, G. P. (2011). Tp53-associated pediatric malignancies. Genes and Cancer, 2(4), 485–490. https://doi.org/10.1177/1947601911409745

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free